Driving Global Research an Clinical Application of Adoptive Cell Therapy
› Welcome to the International Society of CIK Cells
The International Society of CIK Cells (ISCC) is dedicated to advancing patient treatment options through the research and development of cellular therapies, including the use of T cells, NK cells, NKT cells, and Cytokine-Induced Killer (CIK) cells.
CIK cells currently hold a significant role in both research and clinical settings, having already received Iicensure as a therapeutic option in various countries. Notably, over 5,000 patients have been treated with CIK cells in clinical trials with only mild adverse events reported.
Founded in 2024 to foster networking among professionals working with CIK cells, the ISCC serves several critical functions:
- Coordinating the preparation of interdisciplinary guidelines.
- Promoting basic, translational, and clinical research.
- Staodardizing essential documents and protocols.
Dear patients,
dear colleagues,
We are delighted to welcome you to our official homepage.
The ISC'C is dedicated to advancing patient treatment options through the research and development of cellular therapies. particularly those involving Cytokine-lnduced Killer (CIK) cells and related lymphocytes.
For Researchers and Clinicians: Founded in 2024, our mission is to foster global networking and collaboration. We warmly invite you to become a member andjoin our growing community.
For Patients: Please explore the dedicated pages for information on CIK cells, clinical applications, and ongoing trials.
We encourage you to explore the rest of our site for detailed information. Should you have any questions or comments, please do not hesitate to contact us.
Best regards,
Prof. Dr. med. Ingo Schmidt-Wolf
President of the ISCC
